Fig. 1From: Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case reportPlasma chitotriosidase over time on treatment. Chitotriosidase values were evaluated approximately every 6 months. These data showed a reduction in plasma values after the start of combination therapy. ERT Enzyme replacement therapy, SRT Substrate reduction therapyBack to article page